Stock listing
NASDAQ:CNTA Centessa Pharmaceuticals PLC Stock
Follow Centessa Pharmaceuticals PLC into a list and get an email when it puts out news.
Last close · NASDAQ:CNTA
$40.50 USD
Close on Jun 23, 2026 · No longer trades
- Lowest – highest close
- $3.03 – $40.50 USDSince May 28, 2021 · lowest Feb 16, 2023 · highest Jun 23, 2026
Delisted NASDAQ:CNTA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CNTA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Centessa Pharmaceuticals PLC on 6ix
- Decks
- 17 decks · latest Nov 5, 2025
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2025) | Investor deck | 21 slides | Nov 5, 2025 |
| Investor Presentation (January 2025) | Investor deck | 25 slides | Jan 8, 2025 |
| Investor Presentation (November 2024) | Investor deck | 29 slides | Nov 12, 2024 |
| Investor Presentation (September 2024) | Investor deck | 39 slides | Sep 10, 2024 |
| Investor Presentation (April 2024) | Investor deck | 37 slides | Apr 22, 2024 |
| Technical Presentation (February 2024) | Technical | 14 slides | Feb 9, 2024 |
| Investor Presentation (January 2024) | Investor deck | 31 slides | Jan 9, 2024 |
| World Sleep 2023 | Conference | 10 slides | Oct 25, 2023 |
| Investor Presentation (August 2023) | Investor deck | 29 slides | Aug 14, 2023 |
| Investor Presentation (June 2023) | Investor deck | 23 slides | Jun 9, 2023 |
All 17 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2023) | Investor deck | 25 slides | Mar 30, 2023 |
| Technical Presentation (December 2022) | Technical | 15 slides | Dec 12, 2022 |
| Investor Presentation (September 2022) | Investor deck | 27 slides | Sep 12, 2022 |
| Investor Presentation (June 2022) | Investor deck | 41 slides | Jun 2, 2022 |
| Investor Presentation (March 2022) | Investor deck | 46 slides | Mar 30, 2022 |
| Technical Presentation (November 2021) | Technical | 14 slides | Nov 1, 2021 |
| Technical Presentation (September 2021) | Technical | 24 slides | Sep 9, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Atlantic S a r l General Other companies: Liftoff Mobile, Inc. (Director · Since at least Jun 4, 2026); Seaport Therapeutics, Inc. (Director · Since at least May 4, 2026); Alkami Technology, Inc. (Director · Since at least Apr 13, 2021); HireRight Holdings Corp (Director · Nov 16, 2022 – Jun 28, 2024 · Past) | Director · Jun 22, 2023 – Jun 22, 2023 · Past |
| Samarth Kulkarni Other companies: Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Black Diamond Therapeutics, Inc. (CEO, CRISPR Therapeutics AG · Since at least Jan 29, 2020); CRISPR Therapeutics AG (Chief Executive Officer and Chairman of the Board · Since at least Oct 18, 2016); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 17, 2024 · Past) | Director · Since at least May 27, 2021 |
| Arjun Goyal Other companies: JATT III Acquisition Corp (Director · Since at least Aug 25, 2026); JATT II Acquisition Corp (Director · Since at least Apr 16, 2026) | Director · Since at least May 27, 2021 |
| John J Crowley Other companies: Fusion Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2020 – Jun 4, 2024 · Past); Charles River Laboratories International, Inc. (SVP, Chief Accounting Officer · May 24, 2016 – Oct 1, 2016 · Past) | Chief Financial Officer · Since at least Jun 10, 2024 |
| Carol Stuckley Other companies: Epizyme Inc (Director · Nov 16, 2021 – Aug 12, 2022 · Past) | Director · Since at least May 27, 2021 |
| Gregory M Weinhoff Other companies: Sio Gene Therapies Inc (Principal Financial Officer · Apr 29, 2016 – Mar 15, 2018 · Past) | Chief Business Officer · Since at least May 27, 2021 |
| Karen M Anderson Other companies: Mimecast Limited (Chief Human Resources Officer · Jan 3, 2019 – May 19, 2022 · Past) | Chief People Officer · Since at least Nov 30, 2022 |
| Atlantic Cooperatief U A General | Director · Jun 22, 2023 – Jun 22, 2023 · Past |
| David M Chao | Chief Administrative Officer · Sep 30, 2023 – Mar 17, 2025 · Past |
| Harris Rotman | SVP Regulatory Affairs · Feb 1, 2024 – Feb 1, 2024 · Past |
All 13 people
| Person | Seat |
|---|---|
| Iqbal J Hussain | Chief Legal Officer · Since at least May 27, 2021 |
| Raphael Deferiere | Chief Accounting Officer · Since at least May 27, 2025 |
| Tia L Bush | Chief Technology & Quality Ofc · Since at least Jul 1, 2022 |
Log in to ask 6ix AI your own questions about Centessa Pharmaceuticals PLC.